23andMe's Bankruptcy and Lessons for Healthcare Innovation
The downfall of 23andMe this week isn't just another Silicon Valley flameout. It's a cautionary tale for anyone innovating in healthcare.
Ask AI for this week’s Hypepotamus briefing